Ground-breaking Alzheimers blood test

At the European Academy of Neurology Congress in Helsinki, researchers unveiled a groundbreaking blood test that could revolutionize Alzheimer’s disease management by identifying patients with mild cognitive impairment (MCI) likely to progress rapidly to severe Alzheimer’s. This discovery offers renewed hope for families and clinicians seeking to understand and address cognitive decline. Conducted by the...